MCRB EPS Estimates
Seres Therapeutics, Inc.
$2.48
+$0.06(+2.52%)
43
Overall
80
Value
9
Tech
42
Quality
Market Cap
$24.31M
Volume
5.31K
52W Range
$2.42 - $29.98
Target Price
$17.00
MCRB EPS estimates: the consensus estimate for Seres Therapeutics, Inc.'s current fiscal year is -$6.33 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
MCRB EPS Estimates
- EPS estimate, current quarter
- $-1.34
- EPS estimate, next quarter
- $-1.37
- EPS estimate, current year
- $-6.33
- EPS estimate, next year
- $-2.06
- EPS growth, 3-year
- +26.28%
| Fiscal year | EPS |
|---|---|
| 2025 | $0.64 |
| 2023 | $-17.80 |
| 2022 | $-46.20 |
| 2021 | $-14.40 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MCRB | $2.48 | +2.5% | 5.31K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Seres Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW